Treatment of Cutaneous Neurofibromas in Patients with Neurofibromatosis Type 1

Neurofibromatosis type 1 is a genetic disorder impacting approximately 2.5 million people worldwide, often leading to development of numerous benign yet disfiguring cutaneous neurofibromas (cNF). Removal of cNF is limited to excision or laser ablation with common post-operation complications and sca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wozniak, Bartosz, Bove, Torsten, Zawada, Tomasz, Calik, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601743/
https://www.ncbi.nlm.nih.gov/pubmed/37899948
http://dx.doi.org/10.1159/000534270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601743/
https://www.ncbi.nlm.nih.gov/pubmed/37899948
http://dx.doi.org/10.1159/000534270

Ejemplares similares